These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7151222)

  • 1. Structure-activity considerations: a synthesis of ideas.
    Hathway DE
    Chem Biol Interact; 1982 Oct; 42(1):1-26. PubMed ID: 7151222
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships among activity coefficients, partition coefficients and solubilities.
    Bocek K
    Experientia Suppl; 1976; 23():231-40. PubMed ID: 954938
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug absorption kinetics in goldfish.
    Yolkowsky SH; Carpenter OS; Flynn GL; Slunick TG
    J Pharm Sci; 1973 Dec; 62(12):1949-54. PubMed ID: 4762163
    [No Abstract]   [Full Text] [Related]  

  • 4. Parabolic structure-activity relationships: a simple pharmacokinetic model.
    Aarons L; Bell D; Waigh R; Ye Q
    J Pharm Pharmacol; 1982 Nov; 34(11):746-9. PubMed ID: 6129312
    [No Abstract]   [Full Text] [Related]  

  • 5. Prodrug lability prediction through the use of substituent effects.
    Charton M
    Methods Enzymol; 1985; 112():323-40. PubMed ID: 4046853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in Hansch analysis].
    Guo ZR
    Yao Xue Xue Bao; 1983 Mar; 18(3):234-40. PubMed ID: 6349253
    [No Abstract]   [Full Text] [Related]  

  • 7. Concepts in the kinetics of drug administration. I. Theoretical considerations.
    Sixsmith DG
    East Afr Med J; 1981 Apr; 58(4):263-8. PubMed ID: 7261980
    [No Abstract]   [Full Text] [Related]  

  • 8. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.
    Martin YC
    J Med Chem; 1981 Mar; 24(3):229-37. PubMed ID: 7265109
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacodynamic principles in chemical teratology: dose-effect relationships.
    Jusko WJ
    J Pharmacol Exp Ther; 1972 Dec; 183(3):469-80. PubMed ID: 4636387
    [No Abstract]   [Full Text] [Related]  

  • 10. A theoretical approach to structure-activity relationships. Some implications for the concept of optimal lipophilicity [proceedings].
    Dearden JC; Townend MS
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():13P. PubMed ID: 12286
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantum statistical calculation for the correlation of biological activity and chemical structure. 2. Drug-membrane penetrations.
    Lin TK
    J Med Chem; 1974 Jul; 17(7):749-51. PubMed ID: 4836407
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of drug disposition: hemodynamic considerations.
    Wilkinson GR
    Annu Rev Pharmacol; 1975; 15():11-27. PubMed ID: 1096786
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: The receptor concept in evolution.
    Ariëns EJ; Beld AJ
    Biochem Pharmacol; 1977 May; 26(10):913-8. PubMed ID: 324474
    [No Abstract]   [Full Text] [Related]  

  • 14. Saliva-plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications.
    Posti J
    Pharm Acta Helv; 1982; 57(3):83-92. PubMed ID: 7071071
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical salts.
    Berge SM; Bighley LD; Monkhouse DC
    J Pharm Sci; 1977 Jan; 66(1):1-19. PubMed ID: 833720
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative structure-pharmacokinetics relationships and their importance in drug design, possibilities and limitations.
    Seydel JK
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):571-81. PubMed ID: 6513673
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens: introduction.
    NIDA Res Monogr; 1978; (22):1-5. PubMed ID: 101878
    [No Abstract]   [Full Text] [Related]  

  • 18. [Theoretical aspects of ascertaining parameters of action of biologically active compounds].
    Barth A; Franke R; Börnert D
    Pharmazie; 1976 Jun; 31(6):396-401. PubMed ID: 959301
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspectives on alternatives to current animal testing techniques in preclinical toxicology.
    Rowan AN; Goldberg AM
    Annu Rev Pharmacol Toxicol; 1985; 25():225-47. PubMed ID: 3890703
    [No Abstract]   [Full Text] [Related]  

  • 20. MacDope: a simulation of drug disposition in the human body. Mathematical considerations.
    Bloch R; Ingram D; Sweeney GD; Ahmed K; Dickinson CJ
    J Theor Biol; 1980 Nov; 87(2):211-36. PubMed ID: 7230844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.